Siemens Atellica CH Fructosamine Test Recall for Positive Bias
Siemens is recalling Atellica CH Fructosamine tests because results may show a positive bias, potentially leading to incorrect glucose management and hypoglycemia.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product where injury (hypoglycemia) has not yet been reported, fitting the High severity criteria for potential harm without confirmed incidents.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the Atellica CH Systems Fructosamine (FRUC) test, used for the quantitative measurement of glycated protein in human serum or plasma on ADVIA Chemistry systems. The recall involves 28 units in the United States and 255 units outside the US, distributed across various states and foreign countries.
The recall is due to a potential 60 umol/L positive bias in fructosamine results compared to the predicate assay reference. This bias may lead to incorrect adjustments in hyperglycemic therapy, where more aggressive management of glycemia could contribute to hypoglycemia.
Healthcare facilities and laboratories using these tests should stop using the affected lots and contact Siemens for further instructions. Patients who have had recent fructosamine tests should consult their healthcare provider to review their results and current glucose management plans.
The recalled product
- Product
- Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum or plasma on the ADVIA¿ Chemistry systems Siemens Material Number (SMN): 11097637
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Hazard
Distribution
Part of a larger recall action
This product is one of 2 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02